A 20-year longitudinal observational study of somatic antidepressant treatment effectiveness

American Journal of Psychiatry

Volumn 160, Issue 4, 2003, Pages 727-733

  Leon, Andrew C ^a,b   Solomon, David A ^a   Mueller, Timothy I ^a   Endicott, Jean ^a   Rice, John P ^a   Maser, Jack D ^a   Coryell, William ^a   Keller, Martin B ^a  

^a NIMH Collaborative Program on the Psychobiology of Depression   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ARTICLE; DRUG EFFICACY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MENTAL HEALTH SERVICE; MOOD DISORDER; PRIORITY JOURNAL; ADULT; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DEPRESSION; DRUG ADMINISTRATION; EPIDEMIOLOGY; FEMALE; HEALTH SERVICES RESEARCH; HOSPITALIZATION; LONGITUDINAL STUDY; MALE; PATIENT ATTITUDE; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; TREATMENT OUTCOME; UNITED STATES;

ADULT; ANTIDEPRESSIVE AGENTS; BIAS (EPIDEMIOLOGY); DEPRESSIVE DISORDER; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HEALTH SERVICES RESEARCH; HUMANS; LONGITUDINAL STUDIES; MALE; NATIONAL INSTITUTE OF MENTAL HEALTH (U.S.); PATIENT ACCEPTANCE OF HEALTH CARE; PSYCHIATRIC STATUS RATING SCALES; RANDOMIZED CONTROLLED TRIALS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 0038474170     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.160.4.727     Document Type: Article

References (32)

1. Bech P, Cialdella P, Haugh MC, Birkett MA, Hours A, Boissel JP, Tollefson GD: Meta-analysis of randomised controlled trials of fluoxetine v placebo and tricyclic antidepressants in the short-term treatment of major depression. Br J Psychiatry 2000; 176:421-128
2. Claghorn JL, Earl CQ, Walczak DD, Stoner KA, Wong LF, Kanter D, Houser VP: Fluvoxamine maleate in the treatment of major depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients. J Clin Psychopharmacol 1996; 16:113-120
3. Cohn JB, Crowder JE, Wilcox CS, Ryan PJ: A placebo- and imipramine-controlled study of paroxetine. Psychopharmacol Bull 1990; 26:185-189
4. Feighner JP, Boyer WF: Paroxetine in the treatment of depression: a comparison with imipramine and placebo. J Clin Psychiatry 1992; 53(Feb suppl):44-47
5. Feighner JP, Overo K: Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression. J Clin Psychiatry 1999; 60:824-830
6. Lydiard RB, Stahl SM, Hertzman M, Harrison WM: A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression. J Clin Psychiatry 1997; 58:484-491
7. Mendels J, Kiev A, Fabre LF: Double-blind comparison of citalopram and placebo in depressed outpatients with melancholia. Depress Anxiety 1999; 9:54-60
8. Meinert CL: Clinical Trials Dictionary: Terminology and Usage Recommendations. Baltimore, Harbor Duvall Graphics, 1996
9. Zimmerman M, Mattia JI, Posternak MA: Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice? Am J Psychiatry 2002; 159:469-473
10. Partonen T, Sihvo S, Lonnqvist JK: Patients excluded from an antidepressant efficacy trial. J Clin Psychiatry 1996; 57:572-575
11. Cochran WG: The effectiveness of adjustment by subclassification in removing bias in observational studies. Biometrics 1968; 24:295-313
12. Rosenbaum P, Rubin DB: The central role of the propensity score in observational studies for causal effects. Biometrika 1983; 70:41-55
13. Rosenbaum PR, Rubin DB: Reducing bias in observational studies using subclassification on the propensity score. J Am Statistical Assoc 1984; 79:516-524
14. Rubin DB, Rosenbaum PR: Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. Am Statistician 1985; 39:33-38
15. Rubin DB: Estimating causal effects from large data sets using propensity scores. Ann Intern Med 1997; 127:757-763
16. Rosenbaum PR: Discussing hidden bias in observational studies. Ann Intern Med 1991; 115:901-905
17. Rosenbaum PR: Observational Studies. New York, Springer-Verlag, 1995
18. Katz MM, Klerman GL: Introduction: overview of the clinical studies program. Am J Psychiatry 1979; 136:49-51
19. Keller MB, Lavori PW, Mueller TI, Endicott J, Coryell W, Hirschfeld RMA, Shea T: Time to recovery, chronicity and levels of psychopathology in major depression: a prospective follow-up of 431 subjects. Arch Gen Psychiatry 1992; 49:809-816
20. Endicott J, Spitzer RL: A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry 1978; 35:837-844
21. Spitzer RL, Endicott J, Robins E: Research Diagnostic Criteria: rationale and reliability. Arch Gen Psychiatry 1978; 35:773-782
22. Keller MB, Lavori PW, Friedman B, Nielsen E, Endicott J, McDonald-Scott P, Andreasen NC: The Longitudinal Interval Follow-Up Evaluation: a comprehensive method for assessing outcome in prospective longitudinal studies. Arch Gen Psychiatry 1987; 44:540-548
23. Keller MB: Undertreatment of major depression. Psychopharmacol Bull 1988; 24:75-80
24. Leon AC, Mueller TI, Solomon DA, Keller MB: A dynamic adaptation of the propensity score adjustment for effectiveness analyses of ordinal doses of treatment. Stat Med 2001; 20:1487-1498
25. Hedeker D, Gibbons RD: A random-effects ordinal regression model for multilevel analysis. Biometrics 1994; 50:933-944
26. Hedeker D, Gibbons RD: MIXOR: a computer program for mixed-effects ordinal regression analysis. Comput Methods Programs Biomed 1996; 49:157-176
27. Hedeker D, Siddiqui O, Hu FB: Random-effects regression analysis of correlated grouped-time survival data. Stat Methods Med Res 2000; 9:161-179
28. Hedeker D: MIXGSUR: A Computer Program for Mixed-Effects Grouped-Time Survival Analysis: Technical Report. Chicago, University of Illinois at Chicago, 1998
29. Fleiss JL: Statistical Methods for Rates and Proportions, 2nd ed. New York, John Wiley & Sons, 1981
30. Diggle PJ, Liang K-Y, Zeger SL: Analysis of Longitudinal Data. Oxford, UK, Oxford University Press, 1994
31. Endicott J, Cohen J, Nee J, Fleiss JL, Serantakos: Hamilton Depression Rating Scale: extracted from regular and change versions of the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry 1981; 38:98-103
32. Klerman GL: Scientific and ethical considerations in the use of placebo controls in clinical trials in psychopharmacology. Psychopharmacol Bull 1986; 22:25-29